Faisal Khurshid, an analyst from Leerink Partners, maintained the Buy rating on Geron (GERN – Research Report). The associated price target ...

On Friday, Geron Corp (GERN) stock saw a decline, ending the day at $3.57 which represents a decrease of $-0.03 or -0.83% from the prior close of $3.6. The stock opened at $3.63 and touched a low of ...

We recently published a list of the 12 Best Long-Term Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

Highlights,Geron Corporation's focus on treatments for myelodysplastic syndromes gains attention.,Recent European Medicines ...

We recently compiled a list of the 10 Best Penny Stocks to Buy for 2025. In this article, we are going to take a look at ...

Imetelstat sodium is under clinical development by Geron and currently in Phase I for Juvenile Myelomonocytic Leukemia (JMML).

Geron Corporation (NASDAQ:GERN) has a negative Return on Invested Capital (ROIC) of -68.21%, indicating challenges in ...

Geron Co. (NASDAQ:GERN – Get Free Report) has been given a consensus recommendation of “Buy” by the eleven analysts that are ...

On Tuesday, Geron Corp (GERN) stock saw a modest uptick, ending the day at $3.34 which represents no change from the prior close of of $3.34. The stock opened at $3.34 and touched a low of $3.28 ...

Seeking Alpha's Quant system consistently outperforms the S&P 500 ( SP500 ), driven by powerful computer processing and SA's ...

Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 72,000 shares of Geron common ...